Loading…
Supraventricular tachyarrhythmias during the intrauterine, neonatal, and infant period: A 10‐year population‐based study
Background We aimed to evaluate the incidence, type, and management of supraventricular tachyarrhythmias (SVT) during the first year of life in a retrospective, population‐based, single‐center study during a 10‐year period. Methods The analyzed patient cohort is based on data from the only specializ...
Saved in:
| Published in: | Pacing and clinical electrophysiology 2020-07, Vol.43 (7), p.680-686 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c3574-815edf2af2af63c6ffb1370a186d5235e679a98b1950fcc0ec0773e43742af8f3 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c3574-815edf2af2af63c6ffb1370a186d5235e679a98b1950fcc0ec0773e43742af8f3 |
| container_end_page | 686 |
| container_issue | 7 |
| container_start_page | 680 |
| container_title | Pacing and clinical electrophysiology |
| container_volume | 43 |
| creator | Bjeloševič, Marko Illíková, Viera Tomko, Jaroslav Olejník, Peter Chalupka, Michal Hatala, Robert |
| description | Background
We aimed to evaluate the incidence, type, and management of supraventricular tachyarrhythmias (SVT) during the first year of life in a retrospective, population‐based, single‐center study during a 10‐year period.
Methods
The analyzed patient cohort is based on data from the only specialized center managing all cases of neonatal and infant SVTs between 2009 and 2018 in the Slovak Republic (5.5 million population). A total of 116 consecutive patients |
| doi_str_mv | 10.1111/pace.13964 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2407315769</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2407315769</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3574-815edf2af2af63c6ffb1370a186d5235e679a98b1950fcc0ec0773e43742af8f3</originalsourceid><addsrcrecordid>eNp9kd9KHDEUh4NUdNXe9AFKoDcirk0myWTi3bLYKggt1F4PZzNnuiOzM9P8UQZ64SP4jD5JM671oheGQOCcLx_n8CPkA2dnPJ3PA1g848LkcofMuJJsXnBl3pEZ41LPC1GYfXLg_S1jLGdS7ZF9kUllWKZn5M-PODi4wy64xsYWHA1g1yM4tx7DetOAp1V0TfeLhjXSJmEQA6YCntIO-w4CtKcUuir1augCHVKzr87pgnL29PA4YlIO_ZDUoem7VFmBx4r6EKvxiOzW0Hp8__Iekp9fLm6Wl_Prb1-vlovruRVKy2kbrOoMppsLm9f1igvNgBd5pTKhMNcGTLHiRrHaWoaWaS1QCi3Tj6IWh-R46x1c_zuiD-Wm8RbbFtIK0ZeZZFpwpXOT0E__obd9dF2aLlGZMoWWeqJOtpR1vfcO63JwzQbcWHJWTpmUUyblcyYJ_viijKsNVq_ovxASwLfAfdPi-Iaq_L5YXmylfwHCI5oj</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2425987479</pqid></control><display><type>article</type><title>Supraventricular tachyarrhythmias during the intrauterine, neonatal, and infant period: A 10‐year population‐based study</title><source>EBSCOhost SPORTDiscus with Full Text</source><source>Wiley</source><creator>Bjeloševič, Marko ; Illíková, Viera ; Tomko, Jaroslav ; Olejník, Peter ; Chalupka, Michal ; Hatala, Robert</creator><creatorcontrib>Bjeloševič, Marko ; Illíková, Viera ; Tomko, Jaroslav ; Olejník, Peter ; Chalupka, Michal ; Hatala, Robert</creatorcontrib><description>Background
We aimed to evaluate the incidence, type, and management of supraventricular tachyarrhythmias (SVT) during the first year of life in a retrospective, population‐based, single‐center study during a 10‐year period.
Methods
The analyzed patient cohort is based on data from the only specialized center managing all cases of neonatal and infant SVTs between 2009 and 2018 in the Slovak Republic (5.5 million population). A total of 116 consecutive patients <366 days old were included in the study.
Results
Calculated SVT incidence ratio was 1:4500 in the first year of life. AV reentry tachycardia was the leading arrhythmia (49%). SVT in this specific population was frequently a transient problem with spontaneous resolution in 87% of patients during a median 3‐year follow up. Congenital heart disease was common (16%). Intrauterine treatment by drugs administered to mother was safe and effective in preventing unnecessary cesarean deliveries. In arrhythmia termination, amiodarone and propafenone were equally safe and effective, with possible more favorable pharmacodynamics of the former. For prophylactic treatment, sotalol and propafenone were equally safe and effective and became the preferred basis of long‐term drug therapy in our center. However, this therapy requires intensive monitoring during its initiation.
Conclusion
The prognosis of SVT in the first year of life is good: with optimized pharmacological treatment, the need for early catheter ablation and mortality rate are low (<1%) and there is a high rate of spontaneous arrhythmia resolution. Heart failure is a possible predictor of arrhythmia persistence with need for ablation in later life.</description><identifier>ISSN: 0147-8389</identifier><identifier>EISSN: 1540-8159</identifier><identifier>DOI: 10.1111/pace.13964</identifier><identifier>PMID: 32459027</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Ablation ; Amiodarone ; Arrhythmia ; Cardiac arrhythmia ; Congestive heart failure ; Coronary artery disease ; Drug therapy ; Neonates ; Newborn babies ; pediatrics ; Pharmacodynamics ; Population ; Population studies ; Population-based studies ; propafenone ; sotalol ; Tachycardia</subject><ispartof>Pacing and clinical electrophysiology, 2020-07, Vol.43 (7), p.680-686</ispartof><rights>2020 Wiley Periodicals LLC</rights><rights>This article is protected by copyright. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3574-815edf2af2af63c6ffb1370a186d5235e679a98b1950fcc0ec0773e43742af8f3</citedby><cites>FETCH-LOGICAL-c3574-815edf2af2af63c6ffb1370a186d5235e679a98b1950fcc0ec0773e43742af8f3</cites><orcidid>0000-0002-0086-5114 ; 0000-0002-4363-1078 ; 0000-0002-5507-8302 ; 0000-0001-6998-0674 ; 0000-0001-6720-6802 ; 0000-0001-9674-2540</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32459027$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bjeloševič, Marko</creatorcontrib><creatorcontrib>Illíková, Viera</creatorcontrib><creatorcontrib>Tomko, Jaroslav</creatorcontrib><creatorcontrib>Olejník, Peter</creatorcontrib><creatorcontrib>Chalupka, Michal</creatorcontrib><creatorcontrib>Hatala, Robert</creatorcontrib><title>Supraventricular tachyarrhythmias during the intrauterine, neonatal, and infant period: A 10‐year population‐based study</title><title>Pacing and clinical electrophysiology</title><addtitle>Pacing Clin Electrophysiol</addtitle><description>Background
We aimed to evaluate the incidence, type, and management of supraventricular tachyarrhythmias (SVT) during the first year of life in a retrospective, population‐based, single‐center study during a 10‐year period.
Methods
The analyzed patient cohort is based on data from the only specialized center managing all cases of neonatal and infant SVTs between 2009 and 2018 in the Slovak Republic (5.5 million population). A total of 116 consecutive patients <366 days old were included in the study.
Results
Calculated SVT incidence ratio was 1:4500 in the first year of life. AV reentry tachycardia was the leading arrhythmia (49%). SVT in this specific population was frequently a transient problem with spontaneous resolution in 87% of patients during a median 3‐year follow up. Congenital heart disease was common (16%). Intrauterine treatment by drugs administered to mother was safe and effective in preventing unnecessary cesarean deliveries. In arrhythmia termination, amiodarone and propafenone were equally safe and effective, with possible more favorable pharmacodynamics of the former. For prophylactic treatment, sotalol and propafenone were equally safe and effective and became the preferred basis of long‐term drug therapy in our center. However, this therapy requires intensive monitoring during its initiation.
Conclusion
The prognosis of SVT in the first year of life is good: with optimized pharmacological treatment, the need for early catheter ablation and mortality rate are low (<1%) and there is a high rate of spontaneous arrhythmia resolution. Heart failure is a possible predictor of arrhythmia persistence with need for ablation in later life.</description><subject>Ablation</subject><subject>Amiodarone</subject><subject>Arrhythmia</subject><subject>Cardiac arrhythmia</subject><subject>Congestive heart failure</subject><subject>Coronary artery disease</subject><subject>Drug therapy</subject><subject>Neonates</subject><subject>Newborn babies</subject><subject>pediatrics</subject><subject>Pharmacodynamics</subject><subject>Population</subject><subject>Population studies</subject><subject>Population-based studies</subject><subject>propafenone</subject><subject>sotalol</subject><subject>Tachycardia</subject><issn>0147-8389</issn><issn>1540-8159</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kd9KHDEUh4NUdNXe9AFKoDcirk0myWTi3bLYKggt1F4PZzNnuiOzM9P8UQZ64SP4jD5JM671oheGQOCcLx_n8CPkA2dnPJ3PA1g848LkcofMuJJsXnBl3pEZ41LPC1GYfXLg_S1jLGdS7ZF9kUllWKZn5M-PODi4wy64xsYWHA1g1yM4tx7DetOAp1V0TfeLhjXSJmEQA6YCntIO-w4CtKcUuir1augCHVKzr87pgnL29PA4YlIO_ZDUoem7VFmBx4r6EKvxiOzW0Hp8__Iekp9fLm6Wl_Prb1-vlovruRVKy2kbrOoMppsLm9f1igvNgBd5pTKhMNcGTLHiRrHaWoaWaS1QCi3Tj6IWh-R46x1c_zuiD-Wm8RbbFtIK0ZeZZFpwpXOT0E__obd9dF2aLlGZMoWWeqJOtpR1vfcO63JwzQbcWHJWTpmUUyblcyYJ_viijKsNVq_ovxASwLfAfdPi-Iaq_L5YXmylfwHCI5oj</recordid><startdate>202007</startdate><enddate>202007</enddate><creator>Bjeloševič, Marko</creator><creator>Illíková, Viera</creator><creator>Tomko, Jaroslav</creator><creator>Olejník, Peter</creator><creator>Chalupka, Michal</creator><creator>Hatala, Robert</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0086-5114</orcidid><orcidid>https://orcid.org/0000-0002-4363-1078</orcidid><orcidid>https://orcid.org/0000-0002-5507-8302</orcidid><orcidid>https://orcid.org/0000-0001-6998-0674</orcidid><orcidid>https://orcid.org/0000-0001-6720-6802</orcidid><orcidid>https://orcid.org/0000-0001-9674-2540</orcidid></search><sort><creationdate>202007</creationdate><title>Supraventricular tachyarrhythmias during the intrauterine, neonatal, and infant period: A 10‐year population‐based study</title><author>Bjeloševič, Marko ; Illíková, Viera ; Tomko, Jaroslav ; Olejník, Peter ; Chalupka, Michal ; Hatala, Robert</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3574-815edf2af2af63c6ffb1370a186d5235e679a98b1950fcc0ec0773e43742af8f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Ablation</topic><topic>Amiodarone</topic><topic>Arrhythmia</topic><topic>Cardiac arrhythmia</topic><topic>Congestive heart failure</topic><topic>Coronary artery disease</topic><topic>Drug therapy</topic><topic>Neonates</topic><topic>Newborn babies</topic><topic>pediatrics</topic><topic>Pharmacodynamics</topic><topic>Population</topic><topic>Population studies</topic><topic>Population-based studies</topic><topic>propafenone</topic><topic>sotalol</topic><topic>Tachycardia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bjeloševič, Marko</creatorcontrib><creatorcontrib>Illíková, Viera</creatorcontrib><creatorcontrib>Tomko, Jaroslav</creatorcontrib><creatorcontrib>Olejník, Peter</creatorcontrib><creatorcontrib>Chalupka, Michal</creatorcontrib><creatorcontrib>Hatala, Robert</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Pacing and clinical electrophysiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bjeloševič, Marko</au><au>Illíková, Viera</au><au>Tomko, Jaroslav</au><au>Olejník, Peter</au><au>Chalupka, Michal</au><au>Hatala, Robert</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Supraventricular tachyarrhythmias during the intrauterine, neonatal, and infant period: A 10‐year population‐based study</atitle><jtitle>Pacing and clinical electrophysiology</jtitle><addtitle>Pacing Clin Electrophysiol</addtitle><date>2020-07</date><risdate>2020</risdate><volume>43</volume><issue>7</issue><spage>680</spage><epage>686</epage><pages>680-686</pages><issn>0147-8389</issn><eissn>1540-8159</eissn><abstract>Background
We aimed to evaluate the incidence, type, and management of supraventricular tachyarrhythmias (SVT) during the first year of life in a retrospective, population‐based, single‐center study during a 10‐year period.
Methods
The analyzed patient cohort is based on data from the only specialized center managing all cases of neonatal and infant SVTs between 2009 and 2018 in the Slovak Republic (5.5 million population). A total of 116 consecutive patients <366 days old were included in the study.
Results
Calculated SVT incidence ratio was 1:4500 in the first year of life. AV reentry tachycardia was the leading arrhythmia (49%). SVT in this specific population was frequently a transient problem with spontaneous resolution in 87% of patients during a median 3‐year follow up. Congenital heart disease was common (16%). Intrauterine treatment by drugs administered to mother was safe and effective in preventing unnecessary cesarean deliveries. In arrhythmia termination, amiodarone and propafenone were equally safe and effective, with possible more favorable pharmacodynamics of the former. For prophylactic treatment, sotalol and propafenone were equally safe and effective and became the preferred basis of long‐term drug therapy in our center. However, this therapy requires intensive monitoring during its initiation.
Conclusion
The prognosis of SVT in the first year of life is good: with optimized pharmacological treatment, the need for early catheter ablation and mortality rate are low (<1%) and there is a high rate of spontaneous arrhythmia resolution. Heart failure is a possible predictor of arrhythmia persistence with need for ablation in later life.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>32459027</pmid><doi>10.1111/pace.13964</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-0086-5114</orcidid><orcidid>https://orcid.org/0000-0002-4363-1078</orcidid><orcidid>https://orcid.org/0000-0002-5507-8302</orcidid><orcidid>https://orcid.org/0000-0001-6998-0674</orcidid><orcidid>https://orcid.org/0000-0001-6720-6802</orcidid><orcidid>https://orcid.org/0000-0001-9674-2540</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0147-8389 |
| ispartof | Pacing and clinical electrophysiology, 2020-07, Vol.43 (7), p.680-686 |
| issn | 0147-8389 1540-8159 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2407315769 |
| source | EBSCOhost SPORTDiscus with Full Text; Wiley |
| subjects | Ablation Amiodarone Arrhythmia Cardiac arrhythmia Congestive heart failure Coronary artery disease Drug therapy Neonates Newborn babies pediatrics Pharmacodynamics Population Population studies Population-based studies propafenone sotalol Tachycardia |
| title | Supraventricular tachyarrhythmias during the intrauterine, neonatal, and infant period: A 10‐year population‐based study |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T06%3A56%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Supraventricular%20tachyarrhythmias%20during%20the%20intrauterine,%20neonatal,%20and%20infant%20period:%20A%2010%E2%80%90year%20population%E2%80%90based%20study&rft.jtitle=Pacing%20and%20clinical%20electrophysiology&rft.au=Bjelo%C5%A1evi%C4%8D,%20Marko&rft.date=2020-07&rft.volume=43&rft.issue=7&rft.spage=680&rft.epage=686&rft.pages=680-686&rft.issn=0147-8389&rft.eissn=1540-8159&rft_id=info:doi/10.1111/pace.13964&rft_dat=%3Cproquest_cross%3E2407315769%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3574-815edf2af2af63c6ffb1370a186d5235e679a98b1950fcc0ec0773e43742af8f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2425987479&rft_id=info:pmid/32459027&rfr_iscdi=true |